Primary Image

violet background with white rectangles

Clinical Trial

Effects of twice-daily dosing 4-AP on Functional Recovery after Spinal Cord Injury

IRB Protocol Number STU00221545

Contact

Bing Chen bchen03@sralab.org

Objective

Our studies aim to investigate potential Neuro-modulation Therapies with the help of an FDA approved drug in individuals with spinal cord injuries

Your participation will involve a non-invasive, and painless way to stimulate persons with spinal cord injuries, while muscle activity is observed and recorded.

Participants could participate in trials involving:

  • Non-invasive Brain Stimulation
  • Spinal Cord Stimulation
  • Exercise Training
  • Flexible Schedules

Who Can Participate

  • Spinal cord injury between C2–L2  
  • At least 6 months post-injury
  • Complete or incomplete
  • Male or female

Compensation

Opportunities for Compensation

Age Range

18-85

Apply for this Trial

Your information will not be published.

All fields are required.

Featured Quote

More Studies

view all

Latest Updates

view all